SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brera Holdings Plc engages in the business of football division progression, global football player transfer service, sponsorship services, football school services, and consulting services on football projects. The company was founded on June 30, 2022 and is headquartered in Dublin, Ireland.

Brera Holdings PLC - Ordinary Shares - Class B

Brera Holdings PLC

BREA is trending as traders discuss its potential as a crypto treasury play following news of a $300M private placement, with community members comparing it to previous runners like $QMMM. Bullish sentiment is fueled by the company's plans to rebrand as Solmate and focus on Solana-based digital assets, while others caution about potential dilution and the sustainability of the rally. The stock's low float and volatile price action are also driving considerable conversation.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx ($FDX) is trending following its Q1 earnings release, which featured a better-than-expected EPS and revenue. Despite the earnings beat, the stock dipped in after-hours trading as community members discuss the company's soft guidance and concerns around global trade and tariffs. Some traders are speculating about a potential short squeeze and monitoring the upcoming conference call for further insights.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co.

Disney is trending amid discussions around free speech and potential boycotts related to the removal of Jimmy Kimmel's show, sparking debates over political polarization and censorship. The community is divided, with some supporting Disney's decision and others criticizing it as an attack on free speech. Broader conversations include the company's financial performance, streaming strategy, and the impact of political stances on its brand.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Lennar Corp. is trending as investors closely monitor upcoming earnings and anticipate potential impacts from housing market dynamics and interest rate fluctuations. Community discussions revolve around whether Lennar can maintain margins amid affordability challenges and if the Millrose spin-off will affect the stock's performance. Analysts have mixed views, with some lowering price targets while others remain optimistic about Lennar's strategic positioning.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as investors weigh the potential impact of FedEx's earnings and broader concerns about shipping volumes and costs. Community discussions revolve around the stock's high dividend yield and whether it can be sustained, along with speculation about a potential bottom and future price targets. Some traders are also discussing the impact of US-China trade tensions on shipping demand for UPS.

༼ つ ◕_◕ ༽つ gib is a meme coin on Hedera, inspired by the classic copy pasta meme of persistence and community. Born from the viral 2013 Dota 2 Diretide event, gib embodies the power of collective action. As one of the first ASCII-named tokens on-chain, gib merges meme culture with blockchain innovation, helping users explore Hedera, crypto, and tech in a fun, engaging way. ༼ つ ◕_◕ ༽つ gib knowledge

GIB.X is trending as a meme coin on the Hedera network, drawing comparisons to PENGU and DOGE, with the community highlighting its small market cap and potential for significant growth. Many community members emphasize GIB's strong community, meme potential, and the backing of the Hedera Foundation as reasons for its bullish sentiment. The coin is also being discussed in the context of the broader Hedera (HBAR) ecosystem, with some seeing it as a gateway for new users.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending amid discussions around Panasonic's anode-free solid-state battery announcement, with investors speculating about a potential partnership with QS and Tesla. The community is analyzing patent landscapes and commercialization timelines, debating whether this signals validation or competition for QS's technology. Bullish sentiment suggests a possible breakthrough for solid-state batteries, while bears caution about execution risks and insider selling.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as the community anticipates upcoming earnings, with discussions focused on revenue growth, potential profitability, and long-term prospects. Community members speculate on potential buyout or partnership news, particularly regarding Regeneron, while praising the company's technology and market position. Bullish sentiment is fueled by positive financial outlook and confidence in the company's pipeline.

Darden Restaurants, Inc. is a full-service restaurant company, which engages in the provision of restaurant services. It operates through the following segments: Olive Garden, LongHorn Steakhouse, Fine Dining, and Other Business. The Olive Garden segment is the largest full-service dining Italian restaurant operator. The LongHorn Steakhouse segment includes the results of the company-owned LongHorn Steakhouse restaurants. The Fine Dining segment consists of the premium brands that operate within the fine-dining sub-segment of full-service dining and includes the results of its company-owned The Capital Grille and Eddie V's restaurants. The Other Business segment aggregates the remaining brands and includes the results of its company-owned Cheddar's Scratch Kitchen, Yard House, Seasons 52 and Bahama Breeze restaurants, and from franchises and consumer-packaged goods sales. The company was founded by William B. Darden in 1938 and is headquartered in Orlando, FL.

Darden Restaurants, Inc.

Darden Restaurants ($DRI) is trending amid mixed reactions to recent earnings and revenue figures, with some analysts anticipating price target increases. Community discussions highlight momentum traders observing strong tape action and potential range expansion, while others focus on short positions around a key price level. The broader context includes potential catalysts from clean tech initiatives and utility pilot markets.

Wormhole is a cross-chain messaging protocol that enables secure transfers of data or tokens across different blockchain networks. It supports a variety of applications, including DeFi, NFTs, and governance, by allowing data to be moved between blockchains efficiently and securely. Wormhole employs multiple verification methods to ensure the integrity and validity of the data transmitted through its network.

Wormhole

Wormhole ($W.X) is trending as discussions around its cross-chain interoperability heat up, particularly its integration with Ripple and potential to unlock significant cross-chain potential. Community members are actively discussing its updated "W 2.0 Tokenomics" and speculating on price targets, drawing comparisons to other successful crypto projects. The focus remains on Wormhole's role as a 'universal translator' aiming to connect various blockchains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These five health care stocks, all belonging to small- or micro-cap categories, notched the highest jump in Stocktwits followers in the week ended Feb. 7, 2025:GH Research PLC (+103% jump in followers)&nbsp;GH Research PLC focuses on developing mebufotenin-based therapies for treatment-resistant depression. The company’s inhalable candidate, GH001, met its primary endpoint in a Phase 2b trial, showing a significant reduction in depression scores compared to placebo. Secondary endpoints also showed improvements, with no serious adverse events reported.&nbsp;Despite the promising data, GHRS stock fell more than 28% over the past week.Lipella Pharmaceuticals Inc. (+40% jump in followers)Lipella Pharmaceuticals received FDA approval for an Expanded Access Program for LP-310, an oral rinse for treating oral lichen planus. The condition affects around 6 million Americans and currently has no FDA-approved therapies. The program allows patients with serious unmet medical needs to access the treatment outside of clinical trials.&nbsp;Following the announcement, LIPO stock climbed nearly 14% last week.MBX Biosciences Inc. (+39% jump in followers)MBX Biosciences, focused on peptide therapies for endocrine and metabolic disorders, had no major catalyst last week. However, in January, the company reported positive results from a Phase 1 trial of its long-acting GLP-1 receptor antagonist, MBX 1416, which showed a favorable safety profile.&nbsp;MBX shares surged more than 25% over the past week.Rani Therapeutics Holdings Inc. (+29% jump in followers)Rani Therapeutics, which is developing oral alternatives to injectable biologics, shared new preclinical data on its RaniPill capsule for delivering semaglutide. The study showed successful drug delivery with bioavailability and weight-loss effects comparable to subcutaneous administration. The company plans to start Phase 1 trials of a GLP-1/GLP-2 dual agonist in 2025.&nbsp;RANI stock rose over 12% last week.Invivyd Inc. (+21% jump in followers)Invivyd, which focuses on monoclonal antibodies for viral diseases, reported positive data from its ongoing Phase 1/2 trial of VYD2311, a potential alternative to COVID-19 vaccines. The candidate showed strong antiviral activity and a promising safety profile. The data, combined with results from its Phase 3 CANOPY trial, support its potential as a long-acting COVID-19 treatment.&nbsp;Invivyd shares soared over 355% last week.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Woman examining laboratory samples - stock photo | Image source: Getty Images

These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week

These five small-cap pharma and biotech stocks drew heavy attention on Stocktwits last week, driven by key trial results, FDA updates, and promising drug developments.

Equity

Buy Rating Affirmed for Lipella Pharmaceuticals on LP-310's Phase 2a Enrollment and Strategic Advantages

Analyst Jason McCarthy of Maxim Group maintained a Buy rating on Lipella Pharmaceuticals, Inc. (LIPO Research Report), retaining the price target...

Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024

PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) ( Lipella, our , us or the Company ), a clinical-stage biotechnology company addressing serious...

Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference

Chief Medical Officer Dr. Michael Chancellor will discuss hemorrhagic cystitis and the company's lead candidate, LP-10PITTSBURGH, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc...

Lipella Pharmaceuticals (NASDAQ:LIPO) Stock Price Up 2.9%

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO  Get Free Report)s share price rose 2.9% during trading on Friday . The stock traded as high as $1.07 and last traded at $1.05. Approximately...

Lipella Pharmaceuticals files $50M mixed securities shelf

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Lipella Pharmaceuticals (NASDAQ:LIPO) Stock Price Up 10.3%

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO  Get Free Report)s stock price rose 10.3% during mid-day trading on Thursday . The stock traded as high as $1.12 and last traded at $1.09...

Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.

Lipella Pharmaceuticals Inc

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

LIPO
Lipella Pharmaceuticals Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest LIPO News

LIPO Lipella Pharmaceuticals Inc